GlySens, a San Diego, CA-based company that is developing an implantable, long-term continuous glucose monitoring sensor, has received an investment from the West Health Investment Fund.
The amount of the transaction was not disclosed.
Co-founded by Scientific Advisor David A. Gough, PhD, and President and CEO Joseph Y. Lucisano, PhD, GlySens is committed to developing a long term glucose sensor system to continuously monitor glucose levels and enhance the care and treatment of diabetes.
The company’s sensor resides completely under the skin and transmits glucose measurements wirelessly to a convenient external display device, so patients may control their blood sugar levels more effectively.
FinSMEs
14/09/2012